The Milner Therapeutics Symposium is an annual event held in Cambridge, UK, accommodating approximately 500 in-person delegates and over 250 online participants. This symposium provides a significant platform for scientists from both academia and industry to engage in discussions regarding their latest research, particularly focusing on its potential applications in pharmaceutical and biotechnology sectors to advance new treatments. It serves as a crucial networking event, specifically designed to cultivate collaborations among the Milner Therapeutics Institute’s partner organizations.
This year’s symposium will feature a special partnership presentation by Noubar Afeyan, Founder and CEO of Flagship Pioneering. The distinguished roster of plenary speakers also includes Ijeoma Uchegbu (Wolfson College, University of Cambridge), Sam Barrell (LifeArc), Shankar Balasubramanian (Yusuf Hamied Department of Chemistry, University of Cambridge), Jim Glasheen (Cambridge Enterprise), Mina Ryten (UK Dementia Research Institute), and Simon Lovestone (Johnson & Johnson). Registration for the symposium is open to academic researchers, Milner affiliates, Consortium companies, and venture partners.
